Both in Biotechnology
Protalix BioTherapeutics vs Fate Therapeutics
Over the past year PLX returned +7.1% and FATE returned +36.1%; their daily moves had a correlation of 0.14.
PLX +7.1% FATE +36.1%Growth of $1, one year, split-adjusted
| Metric | PLX | FATE |
|---|---|---|
| Price | $2.55 | $2.11 |
| Market cap | $205.5M | $252.8M |
| Today | −0.78% | +0.96% |
| 1 month | −7.3% | −9.4% |
| 6 months | +17.0% | +58.6% |
| Year to date | +41.7% | +114.7% |
| 1 year | +12.3% | +41.6% |
| Revenue growth (YoY) | +27.1% | +9.2% |
| Gross margin | 61.0% | 100.0% |
| Net margin | 19.0% | −1448.6% |
| P/E (TTM) | 10.8× | — |
| Price / sales | 2.5× | 38.9× |
| Net cash | $40.7M | $153.8M |
| Dividend yield | — | — |
| Volatility (60d) | 45.4% | 60.6% |
| Short % of float | 4.1% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).